Natural killer cell-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation in mouse models of type 2 diabetes
作者机构:The Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation of Jiangsu ProvinceChina Pharmaceutical University210009 NanjingChina State Key Laboratory of Natural MedicinesMinistry of EducationChina Pharmaceutical University210009 NanjingChina
出 版 物:《Signal Transduction and Targeted Therapy》 (信号转导与靶向治疗(英文))
年 卷 期:2021年第6卷第12期
页 面:3783-3795页
核心收录:
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金:This work was supported by grants from the Project Program of State Key Laboratory of Natural Medicines(SKLNMZZCX201821,SKLNMZZ202028) the National Science and Technology Major Projects of New Drugs(2019ZX09301124,2019ZX09201001,and 2019ZX09301-110)in China This work was also supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions(PAPD) China Postdoctoral Science Foundation(2017M621884,2020M681787) “Double First-Class”University project of China Pharmaceutical University(CPU2018GY13,CPU2018PZH03)
主 题:inflammation miR124 killer
摘 要:Natural killer(NK)cells have been suggested to be associated with type 2 diabetes by regulating systemic ***,the mechanism by which NK cells regulate insulin sensitivity remains *** study shows that NK-derived exosomes from lean mice attenuate obesity-induced insulin resistance and inflammation in mice of type 2 ***,lean NK-derived exosomes enhance insulin sensitivity and relieve inflammation in adipocytes and ***-1249-3p,which is significantly upregulated in lean NK-derived exosomes,can be transferred from NK cells to adipocytes and hepatocytes via *** exosomal miR-1249-3p dramatically induces cellular insulin sensitivity and relieves ***,exosomal miR-1249-3p directly targets SKOR1 to regulate the formation of ternary complex SMAD6/MYD88/SMURF1,which mediates glucose homeostasis by suppressing the TLR4/NF-κB signaling *** study reveals an emerging role for NK-derived exosomal miR1249-3p in remission of insulin resistance,and provides a series of potential therapeutic targets in type 2 diabetes.